Diabetes
Showing of 47 results
From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
Ian Neeland, MD, explains how incretin therapies are improving outcomes in cardiovascular, metabolic, and related conditions, while exploring mechanisms, muscle preservation, and strategies for long-term success.
University Hospitals Is the First Ohio Site to Offer Breakthough Lantidra Treatment for Type 1 Diabetes
Innovations in Diabetes & Endocrinology | Spring 2026
University Hospitals Launches Diabetes on Demand Virtual Care Program
Innovations in Diabetes & Endocrinology | Spring 2026
Harrison Kaufman, MD, Joins UH Diabetes & Metabolic Care Center
Innovations in Diabetes & Metabolic Care | Fall 2025
Nutritional Interventions to Prevent and Manage Chronic Kidney Disease in Diabetes
Innovations in Diabetes & Metabolic Care | Spring 2025
The Role of Exercise in Managing Diabetes-Induced Neuropathy
Innovations in Diabetes & Metabolic Care | Spring 2025 It is estimated that 20 million Americans are living with diabetic neuropathy, a condition that affects patients with both type 1 and type 2 diabetes mellitus. Claudia Lewis, MMS, PA-C ...
University Hospitals Offers Infusion Shown to Delay Progression of Type 1 Diabetes
Innovations in Diabetes & Metabolic Care | Fall 2024